Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477–91.

PubMed  Article  Google Scholar 

Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2016;2:16018.

PubMed  Article  Google Scholar 

Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599–616.

PubMed  Article  Google Scholar 

Nguyen LK, Kholodenko BN, von Kriegsheim A. Rac1 and RhoA: Networks, loops and bistability. Small GTPases. 2018;9:316–21.

CAS  PubMed  Article  Google Scholar 

Remorino A, De Beco S, Cayrac F, Di Federico F, Cornilleau G, Gautreau A, et al. Gradients of Rac1 nanoclusters support spatial patterns of Rac1 signaling. Cell Rep. 2017;21:1922–35.

CAS  PubMed  Article  Google Scholar 

Winge MC, Ohyama B, Dey CN, Boxer LM, Li W, Ehsani-Chimeh N, et al. RAC1 activation drives pathologic interactions between the epidermis and immune cells. J Clin Invest. 2016;126:2661–77.

PubMed  PubMed Central  Article  Google Scholar 

Acevedo A, Gonzalez-Billault C. Crosstalk between Rac1-mediated actin regulation and ROS production. Free Radic Biol Med. 2018;116:101–13.

CAS  PubMed  Article  Google Scholar 

Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M, et al. Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer. Mol Cancer. 2019;18:171.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zou T, Mao X, Yin J, Li X, Chen J, Zhu T, et al. Emerging roles of RAC1 in treating lung cancer patients. Clin Genet. 2017;91:520–8.

CAS  PubMed  Article  Google Scholar 

Bayo J, Fiore EJ, Dominguez LM, Cantero MJ, Ciarlantini MS, Malvicini M, et al. Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma. Gut. 2021;70:1362–74.

CAS  PubMed  Article  Google Scholar 

Takenaka N, Nihata Y, Ueda S, Satoh T. In situ detection of the activation of Rac1 and RalA small GTPases in mouse adipocytes by immunofluorescent microscopy following in vivo and ex vivo insulin stimulation. Cell Signal. 2017;39:108–17.

CAS  PubMed  Article  Google Scholar 

Akula MK, Ibrahim MX, Ivarsson EG, Khan OM, Kumar IT, Erlandsson M, et al. Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions. Nat Commun. 2019;10:3975.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lorente M, Garcia-Casas A, Salvador N, Martinez-Lopez A, Gabicagogeascoa E, Velasco G, et al. Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1. 2019;132:jcs234120, 1–12.

Oberoi-Khanuja TK, Rajalingam K. Ubiquitination of Rac1 by inhibitors of apoptosis (IAPs). Methods Mol Biol. 2014;1120:43–54.

CAS  PubMed  Article  Google Scholar 

Oberoi TK, Dogan T, Hocking JC, Scholz RP, Mooz J, Anderson CL, et al. IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J. 2012;31:14–28.

CAS  PubMed  Article  Google Scholar 

Torrino S, Visvikis O, Doye A, Boyer L, Stefani C, Munro P, et al. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1. Dev Cell. 2011;21:959–65.

CAS  PubMed  Article  Google Scholar 

Li T, Qin JJ, Yang X, Ji YX, Guo F, Cheng WL, et al. The ubiquitin E3 ligase TRAF6 exacerbates ischemic stroke by ubiquitinating and activating Rac1. J Neurosci. 2017;37:12123–40.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Frances D, Sharma N, Pofahl R, Maneck M, Behrendt K, Reuter K, et al. A role for Rac1 activity in malignant progression of sebaceous skin tumors. Oncogene 2015;34:5505–12.

CAS  PubMed  Article  Google Scholar 

McBeath R, Edwards RW, O’Hara BJ, Maltenfort MG, Parks SM, Steplewski A, et al. Tendinosis develops from age- and oxygen tension-dependent modulation of Rac1 activity. Aging Cell. 2019;18:e12934.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Marston DJ, Anderson KL, Swift MF, Rougie M, Page C, Hahn KM, et al. High Rac1 activity is functionally translated into cytosolic structures with unique nanoscale cytoskeletal architecture. Proc Natl Acad Sci USA. 2019;116:1267–72.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol. 2009;11:56–64.

CAS  PubMed  Article  Google Scholar 

Liu W, Wang G, Zhang C, Ding W, Cheng W, Luo Y, et al. MG53, A novel regulator of KChIP2 and Ito,f, plays a critical role in electrophysiological remodeling in cardiac hypertrophy. Circulation. 2019;139:2142–56.

CAS  PubMed  Article  Google Scholar 

Bian Z, Wang Q, Zhou X, Tan T, Park KH, Kramer HF, et al. Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function. Nat Commun. 2019;10:4659.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Wu HK, Zhang Y, Cao CM, Hu X, Fang M, Yao Y, et al. Glucose-sensitive myokine/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis. Circulation. 2019;139:901–14.

CAS  PubMed  Article  Google Scholar 

Sermersheim M, Kenney AD, Lin PH, McMichael TM, Cai C, Gumpper K, et al. MG53 suppresses interferon-beta and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling. Nat Commun. 2020;11:3624.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Yi JS, Park JS, Ham YM, Nguyen N, Lee NR, Hong J, et al. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun. 2013;4:2354.

PubMed  Article  Google Scholar 

Jaworska AM, Wlodarczyk NA, Mackiewicz A, Czerwinska P. The role of TRIM family proteins in the regulation of cancer stem cell self-renewal. Stem Cells. 2020;38:165–73.

CAS  PubMed  Article  Google Scholar 

Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42:297–311.

CAS  PubMed  Article  Google Scholar 

Song R, Peng W, Zhang Y, Lv F, Wu HK, Guo J, et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494:375–9.

CAS  PubMed  Article  Google Scholar 

Lionarons DA, Hancock DC, Rana S, East P, Moore C, Murillo MM, et al. RAC1(P29S) induces a mesenchymal phenotypic switch via serum response factor to promote melanoma development and therapy resistance. Cancer Cell. 2019;36:68–83.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jiang ZB, Ma BQ, Liu SG, Li J, Yang GM, Hou YB, et al. miR-365 regulates liver cancer stem cells via RAC1 pathway. Mol Carcinog. 2019;58:55–65.

CAS  PubMed  Article  Google Scholar 

Wei L, Lee D, Law CT, Zhang MS, Shen J, Chin DW, et al. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019;10:4681.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Zhu YJ, Zheng B, Wang HY, Chen L. New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharm Sin. 2017;38:614–22.

CAS  Article  Google Scholar 

Li Q, Ren B, Gui Q, Zhao J, Wu M, Shen M, et al. Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression. Ann Transl Med. 2020;8:1305.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dietrich P, Koch A, Fritz V, Hartmann A, Bosserhoff AK, Hellerbrand C. Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance. Gut. 2018;67:1328–41.

CAS  PubMed  Article  Google Scholar 

Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia X, et al. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci Rep. 2014;4:6248.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bao Z, Zhang L, Li L, Yan J, Pang Q, Sun Z, et al. Nepsilon-carboxymethyl-lysine negatively regulates foam cell migration via the Vav1/Rac1 pathway. J Immunol Res. 2020;2020:1906204.

PubMed  PubMed Central  Google Scholar 

Navarro-Lerida I, Sanchez-Perales S, Calvo M, Rentero C, Zheng Y, Enrich C, et al. A palmitoylation switch mechanism regulates Rac1 function and membrane organization. EMBO J. 2012;31:534–51.

CAS  PubMed  Article  Google Scholar